USPTO serial 77519419
SLEEPWELL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- AYALA, LOURDES
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SLEEPWELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRAIL NORTHTHIRD FLOORNAPLES, FL 34103-3590Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Botanical extracts, namely, plant extracts for medical or pharmaceutical purposes; plant extracts for medical and nutritional purposes; plant extracts for medical and pharmaceutical purpose; plant extracts for medical and nutraceutical purposes; botanical extracts for use in the manufacture of nutraceuticals; botanical extracts for use in the manufacture of pharmaceutical preparations, namely, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; all natural chemical additives made from extracts and active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; all natural chemical additives made from extracts and active principles extracted from medicinal plants for use in the pharmaceutical industry, namely, chemical agents made from botanical extracts and an association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts used in the manufacture of preparations, namely, lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts used in the manufacture of pharmaceutical preparations, namely, lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; all natural chemical nutritional additives for use in the manufacture of foods and dietary supplements for human consumption for medical or non- medical purposes; all natural chemical additives made from botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; all natural chemical additives made from herbal extracts and herbal blends for use in the manufacture of functional foods or beverages; all natural chemical additives made from herbal extracts and herbal blends for use in medicinal foods or beverages; botanical extracts and blends for use in the manufacture of functional foods and beverages; botanical extracts and blends for use in the manufacture of medicinal foods and beverages; designer extracts, namely, all natural chemical additives made from herbal extracts for use in making medical, veterinary and pharmaceutical preparations; botanical extracts and blends, namely, herbal and algal ingredients for use in making cosmetics; botanical extracts and blends, namely, algal ingredients for medical or pharmaceutical purposes; botanical and herbal extracts for use in making medical, veterinary and pharmaceutical preparations; designer botanical and herbal extracts, namely, plant, herbal and botanical extracts for use in making medical, veterinary and pharmaceutical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 3, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 29, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 17, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 26, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 2, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 30, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 29, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 23, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jul 14, 2008 | NWAP | NEW APPLICATION ENTERED | — |